Dr. Paul E. Schulz

Professor and Vice Chair Department of Neurology McGovern Medical School at UTHealth Director Dementia Program UTHealth Neurosciences Mischer Neuroscience Institute Dr. Paul Schulz, M.D., is a Professor of Neurology, and Director of the Memory Disorders and Dementia Clinic at McGovern Medical School. He received his combined BA-MD degrees from Boston University in 1984. He did a medical internship there, and moved to Baylor College of Medicine for his Residency in Neurology. He stayed for a laboratory Fellowship in Cellular Neurophysiology after which he became an Assistant Professor. Later, he was an Associate Professor of Neurology, Neuroscience, and Translational Biology and Molecular Medicine. Dr. Schulz was also the Vice Chair of Education for Neurology, the Deputy Chair of the Methodist Neurology Service, and Directed the Cognitive Disorders Clinics at Baylor and the Houston Veterans Administration Hospital. Dementia Program In 2010, Dr. Schulz moved to Mischer Neuroscience Institute and UTHealth Neurosciences, where he sees patients who have cognitive, behavioral, or mood disorders. His group is investigating risk factors for dementia in order to understand why it develops, including both environmental and genetic factors. They use imaging, epidemiologic, and genetic approaches and have identified several risk factors. They are also investigating ways to diagnose dementia earlier, perhaps before symptoms develop, in order to determine whether interventions in the presymptomatic stage might delay or prevent the development of dementia. His group has early data suggesting that the treatment of some risk factors may reduce the probability of developing dementia. Dr. Schulz has received numerous awards and has been an invited speaker at major scientific meetings worldwide. He has been extensively published in the scientific literature and has been featured on television and radio shows.

Dr. Schulz is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Neuronal Intranuclear Inclusion Disease (NIID), Normal Pressure Hydrocephalus, and Deep Brain Stimulation.

He is actively involved in clinical research, co-authoring 104 peer reviewed articles and participating in 8 clinical trials. Dr. Schulz is currently accepting new patients.